NCT05613088
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05613088
Title A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ISR | ESP | BEL | AUS

Facility Status City State Zip Country Details
Local Institution - 0065 Sacramento California 95817 United States Details
Local Institution - 0025 San Francisco California 94109 United States Details
Local Institution - 0078 Whittier California 90602-3171 United States Details
Local Institution - 0081 South Bend Indiana 46601-1033 United States Details
Local Institution - 0043 Kansas City Kansas 66160 United States Details
Local Institution - 0023 Canton Ohio 44710-1702 United States Details
Local Institution - 0061 Columbus Ohio 43219 United States Details
Local Institution - 0044 Nashville Tennessee 37203-1625 United States Details
Local Institution - 0082 Salt Lake City Utah 84124 United States Details
Local Institution - 0042 Spokane Washington 99204 United States Details
Local Institution - 0016 Sydney New South Wales 2065 Australia Details
Local Institution - 0017 Waratah New South Wales 2298 Australia Details
Local Institution - 0031 Chermside Queensland 4032 Australia Details
Local Institution - 0015 Clayton Victoria 3168 Australia Details
Local Institution - 0027 Malvern Victoria 3144 Australia Details
Local Institution - 0058 Nedlands Western Australia 6009 Australia Details
Local Institution - 0032 Leuven VBR 3000 Belgium Details
Local Institution - 0013 Namur WNA 5000 Belgium Details
Local Institution - 0012 Brussels 1200 Belgium Details
Local Institution - 0045 Liège 4000 Belgium Details
Local Institution - 0030 Santiago RM 8420323 Chile Details
Local Institution - 0036 Santiago 7510032 Chile Details
Local Institution - 0029 Temuco 4800827 Chile Details
Local Institution - 0046 Jerusaelm JM 9112001 Israel Details
Local Institution - 0054 Haifa 31999 Israel Details
Local Institution - 0080 Jerusalem 91031 Israel Details
Local Institution - 0055 Ramat Gan 5265601 Israel Details
Local Institution - 0048 Tel Aviv 64239 Israel Details
Local Institution - 0003 Bologna BO 40138 Italy Details
Local Institution - 0011 Milan MI 20132 Italy Details
Local Institution - 0009 Milan MI 20141 Italy Details
Local Institution - 0010 Roma RM 00168 Italy Details
Local Institution - 0002 Brescia 25123 Italy Details
Local Institution - 0018 Akashi, Hyogo 673-8558 Japan Details
Local Institution - 0019 Chūōku 104-0045 Japan Details
Local Institution - 0014 Hidaka-shi 350-1298 Japan Details
Local Institution - 0004 Kurume-Shi 830-0011 Japan Details
Local Institution - 0037 Tokyo 135-8550 Japan Details
Local Institution - 0056 Seoul 03080 South Korea Details
Local Institution - 0049 Seoul 03722 South Korea Details
Local Institution - 0053 Seoul 5505 South Korea Details
Local Institution - 0039 Barcelona B 08035 Spain Details
Local Institution - 0005 Madrid M 28007 Spain Details
Local Institution - 0001 Madrid M 28041 Spain Details
Local Institution - 0007 Valencia V 46009 Spain Details
Local Institution - 0006 Valencia V 46010 Spain Details
Local Institution - 0021 Barcelona 08036 Spain Details
Local Institution - 0020 Girona 17007 Spain Details
Local Institution - 0038 Madrid 28033 Spain Details
Local Institution - 0022 Madrid 28046 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field